RESUMEN
A significant drop in tuberculosis (TB) case-finding has been widely reported during the period of the COVID-19 pandemic. To address a decrease in TB notification, Belarus introduced laboratory TB testing in patients with the laboratory-confirmed coronavirus disease 2019 (COVID-19). We conducted a secondary analysis of health records among 844 patients with laboratory-confirmed COVID-19 diagnosis who were admitted to repurposed departments at TB hospitals and who were tested by Xpert MTB/RIF (Cepheid Inc., Sunnyvale, CA, USA) in five Belarus regions between April and October 2021. Quantitative analysis followed by 13 individual interviews with health managers, physicians, and nurses participating in the intervention. Most patients were male (64%) and mean age was 43.5 ± 16 years. One in twenty (n = 47, 5.6%) patients were co-infected with active pulmonary TB, and over one-third of them (n = 18) had rifampicin resistance. In-hospital mortality was comparable in patients with and without TB co-infection (2.1% and 2.3% respectively, p > 0.99). Laboratory TB testing among patients with COVID-19 at repurposed departments of TB hospitals is feasible in Belarus and may improve TB case-finding.
Asunto(s)
Antibióticos Antituberculosos , COVID-19 , Coinfección , Tuberculosis Latente , Mycobacterium tuberculosis , Tuberculosis , Adulto , Antibióticos Antituberculosos/uso terapéutico , COVID-19/epidemiología , Prueba de COVID-19 , Coinfección/tratamiento farmacológico , Coinfección/epidemiología , Hospitalización , Humanos , Tuberculosis Latente/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Pandemias , República de Belarús/epidemiología , Rifampin , Sensibilidad y Especificidad , Tuberculosis/diagnóstico , Tuberculosis/tratamiento farmacológico , Tuberculosis/epidemiologíaRESUMEN
OBJECTIVE OF THE STUDY: We sought to understand gaps in reporting childhood TB cases among public and private sector health facilities (dubbed "non-NTP" facilities) outside the network of national TB control programmes, and the resulting impact of under-reporting on estimates of paediatric disease burden and market demand for new medicines. METHODOLOGY: Exploratory assessments were carried out in Indonesia, Nigeria and Pakistan, reaching a range of facility types in two selected areas of each country. Record reviews and interviews of healthcare providers were carried out to assess numbers of unreported paediatric TB cases, diagnostic pathways followed and treatment regimens prescribed. MAIN FINDINGS: A total of 985 unreported diagnosed paediatric TB cases were identified over a three month period in 2013 in Indonesia from 64 facilities, 463 in Pakistan from 35 facilities and 24 in Nigeria from 20 facilities. These represent an absolute additional annualised yield to 2013 notifications reported to WHO of 15% for Indonesia, 2% for Nigeria and 7% for Pakistan. Only 12% of all facilities provided age and sex-disaggregated data. Findings highlight the challenges of confirming childhood TB. Diagnosis patterns in Nigeria highlight a very low suspicion for childhood TB. Providers note the need for paediatric medicines aligned to WHO recommendations. CONCLUSION HOW MARKET DATA CAN SUPPORT BETTER PUBLIC HEALTH INTERVENTIONS: This study emphasises the impact of incomplete reporting on the estimation of disease burden and potential market size of paediatric TB medicines. Further studies on "hubs" (facilities treating large numbers of childhood TB cases) will improve our understanding of the epidemic, support introduction efforts for new treatments and better measure markets for new paediatric medicines.
Asunto(s)
Antituberculosos/uso terapéutico , Notificación de Enfermedades/estadística & datos numéricos , Sector de Atención de Salud/estadística & datos numéricos , Tuberculosis/economía , Tuberculosis/epidemiología , Antituberculosos/economía , Niño , Comunicación , Humanos , Indonesia/epidemiología , Nigeria/epidemiología , Pakistán/epidemiología , Tuberculosis/tratamiento farmacológicoRESUMEN
Latent tuberculosis infection (LTBI) is characterised by the presence of immune responses to previously acquired Mycobacterium tuberculosis infection without clinical evidence of active tuberculosis (TB). Here we report evidence-based guidelines from the World Health Organization for a public health approach to the management of LTBI in high risk individuals in countries with high or middle upper income and TB incidence of <100 per 100â000 per year. The guidelines strongly recommend systematic testing and treatment of LTBI in people living with HIV, adult and child contacts of pulmonary TB cases, patients initiating anti-tumour necrosis factor treatment, patients receiving dialysis, patients preparing for organ or haematological transplantation, and patients with silicosis. In prisoners, healthcare workers, immigrants from high TB burden countries, homeless persons and illicit drug users, systematic testing and treatment of LTBI is conditionally recommended, according to TB epidemiology and resource availability. Either commercial interferon-gamma release assays or Mantoux tuberculin skin testing could be used to test for LTBI. Chest radiography should be performed before LTBI treatment to rule out active TB disease. Recommended treatment regimens for LTBI include: 6 or 9â month isoniazid; 12â week rifapentine plus isoniazid; 3-4â month isoniazid plus rifampicin; or 3-4â month rifampicin alone.
Asunto(s)
Antituberculosos/uso terapéutico , Isoniazida/uso terapéutico , Tuberculosis Latente/tratamiento farmacológico , Rifampin/análogos & derivados , Rifampin/uso terapéutico , Antirreumáticos/uso terapéutico , Coinfección/epidemiología , Comorbilidad , Manejo de la Enfermedad , Consumidores de Drogas , Emigrantes e Inmigrantes , Medicina Basada en la Evidencia , Infecciones por VIH/epidemiología , Personal de Salud , Personas con Mala Vivienda , Humanos , Ensayos de Liberación de Interferón gamma , Fallo Renal Crónico/epidemiología , Fallo Renal Crónico/terapia , Tuberculosis Latente/diagnóstico , Tuberculosis Latente/epidemiología , Tamizaje Masivo , Guías de Práctica Clínica como Asunto , Prisioneros , Salud Pública , Radiografía Torácica , Diálisis Renal , Medición de Riesgo , Silicosis/epidemiología , Trastornos Relacionados con Sustancias/epidemiología , Receptores de Trasplantes , Prueba de Tuberculina , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Organización Mundial de la SaludRESUMEN
Increasing attention is being given to the challenges of management and prevention of tuberculosis in children and adolescents. There have been a number of recent important milestones achieved at the global level to address this previously neglected disease. There is now a need to increase activities and build partnerships at the regional and national levels in order to address the wide policy-practice gaps for implementation, and to take the key steps outlined in the Roadmap for Child Tuberculosis published in 2013. In this article, we provide the rationale and suggest strategies illustrated with examples to improve diagnosis, management, outcomes and prevention for children with tuberculosis in the Asia-Pacific region, with an emphasis on the need for greatly improved recording and reporting. Effective collaboration with community engagement between the child health sector, the National Tuberculosis control Programmes, community-based services and the communities themselves are essential.
Asunto(s)
Planificación en Salud Comunitaria , Programas Nacionales de Salud , Tuberculosis/diagnóstico , Tuberculosis/terapia , Adolescente , Asia , Niño , Preescolar , Política de Salud , Humanos , Lactante , Recién Nacido , Tuberculosis/prevención & control , Adulto JovenRESUMEN
Tuberculosis affected an estimated 8.8 million people and caused 1.4 million deaths globally in 2010, including a half-million women and at least 64 000 children. It also results in nearly 10 million cumulative orphans due to parental deaths. Moreover, it causes 6%-15% of all maternal mortality, which increases to 15%-34% if only indirect causes are considered. Increasingly, more women with tuberculosis are notified than men in settings with a high prevalence of human immunodeficiency virus (HIV), and maternal tuberculosis increases the vertical transmission of HIV. Tuberculosis prevention, diagnosis, and treatment services should be included as key interventions in the integrated management of pregnancy and child health. Tuberculosis screening using a simple clinical algorithm that relies on the absence of current cough, fever, weight loss, and night sweats should be used to identify eligible pregnant women living with HIV for isoniazid preventive therapy or for further investigation for tuberculosis disease as part of services for prevention of vertical HIV transmission. While implementing these simple, low-cost, effective interventions as part of maternal, neonatal, and child health services, the unmet basic and operational tuberculosis research needs of children, pregnant, and breastfeeding women should be addressed. National policy makers, program managers, and international stakeholders (eg, United Nations bodies, donors, and implementers) working on maternal, neonatal, and child health, especially in HIV-prevalent settings, should give due attention and include tuberculosis prevention, diagnosis, and treatment services as part of their core functions and address the public health impacts of tuberculosis in their programs and services.
Asunto(s)
Servicios de Salud del Niño/organización & administración , Transmisión Vertical de Enfermedad Infecciosa/prevención & control , Servicios de Salud Materna/organización & administración , Complicaciones Infecciosas del Embarazo/prevención & control , Tuberculosis/prevención & control , Tuberculosis/transmisión , Adulto , Antituberculosos/administración & dosificación , Antituberculosos/uso terapéutico , Niño , Femenino , Salud Global , Humanos , Recién Nacido , Masculino , Embarazo , Complicaciones Infecciosas del Embarazo/tratamiento farmacológico , Complicaciones Infecciosas del Embarazo/epidemiología , Tuberculosis/tratamiento farmacológico , Tuberculosis/epidemiologíaRESUMEN
Childhood tuberculosis (TB) is a preventable and curable infectious disease that remains overlooked by public health authorities, health policy makers and TB control programmes. Childhood TB contributes significantly to the burden of disease and represents the failure to control transmission in the community. Furthermore, the pool of infected children constitutes a reservoir of infection for the future burden of TB. It is time to prioritise childhood TB, advocate for addressing the challenges and grasp the opportunities in its prevention and control. Herein, we propose a scientifically informed advocacy agenda developed at the International Childhood TB meeting held in Stockholm, Sweden, from March 17 to 18, 2011, which calls for a renewed effort to improve the situation for children affected by Mycobacterium tuberculosis exposure, infection or disease. The challenges and needs in childhood TB are universal and apply to all settings and must be addressed more effectively by all stakeholders.
Asunto(s)
Tuberculosis/prevención & control , Tuberculosis/transmisión , Niño , Control de Enfermedades Transmisibles , Política de Salud , Promoción de la Salud/métodos , Humanos , Infectología/tendencias , Mycobacterium tuberculosis/metabolismo , Pobreza , Riesgo , Organización Mundial de la SaludRESUMEN
Tuberculosis is an increasingly serious problem in the WHO European region, particularly in the countries of eastern Europe, the Baltic States, and the Commonwealth of Independent States (CIS).Primary health care providers can play an important role in tuberculosis control through early detection of the disease, referral for treatment, and involvement in directly observed treatment. This guide has been written with the aim of developing the knowledge, awareness and skills of primary health care providers regarding tuberculosis and its prevention and control. The guide is not intended as a complete source of information on tuberculosis, but rather a summary of general principles regarding prevention, detection and treatment. The guide does not reflect specific national guidelines on TB control, and is intended to be used in conjunction with the appropriate national regulations. A reference card containing key information is included with this guide.
Asunto(s)
Tuberculosis , Tuberculosis Resistente a Múltiples Medicamentos , Atención Primaria de Salud , Europa Oriental , Países Bálticos , Comunidad de Estados IndependientesRESUMEN
It describes the burden of tuberculosis in prisons, highlights the difficulties in implementing effective tuberculosis control, outlines the benefits of control of tuberculosis, and provides guidance for establishing and running tuberculosis control services and for the detection and cure of prisoners with tuberculosis.A version in Rusian is available. Document in pdf format; Acrobat Reader needed.
Asunto(s)
Tuberculosis/epidemiología , Tuberculosis/prevención & control , Tuberculosis/terapia , Prisioneros , Prisiones , Obras de Referencia , Vigilancia SanitariaRESUMEN
It describes the burden of tuberculosis in prisons, highlights the difficulties in implementing effective tuberculosis control, outlines the benefits of control of tuberculosis, and provides guidance for establishing and running tuberculosis control services and for the detection and cure of prisoners with tuberculosis.A version in Rusian is available. Document in pdf format; Acrobat Reader needed